The objective of this study was to examine the potential correlation between serum levels of specific biomarkers, including presepsin, apelin, and irisin, which have not been previously investigated in the presence of cutaneous leishmaniasis, and the clinical features, location, number, and size of lesions in patients with cutaneous leishmaniasis. This evidence concerns the gene APLN and cutaneous leishmaniasis.